The Spread of Artemisinin-resistant Plasmodium Falciparum in the Greater Mekong Subregion: a Molecular Epidemiology Observational Study

Overview

Journal Lancet Infect Dis

Specialty Infectious Diseases

Date 2017 Feb 6

PMID 28161569

Citations 254

Authors

Mallika Imwong

Kanokon Suwannasin

Chanon Kunasol

Kreepol Sutawong

Mayfong Mayxay

Huy Rekol

Frank M Smithuis

Tin Maung Hlaing

Kyaw M Tun

Rob W van der Pluijm

Rupam Tripura

Olivo Miotto

Didier Menard

Mehul Dhorda

Nicholas P J Day

Nicholas J White

Arjen M Dondorp

Affiliations

Soon will be listed here.

Abstract

Background: Evidence suggests that the PfKelch13 mutations that confer artemisinin resistance in falciparum malaria have multiple independent origins across the Greater Mekong subregion, which has motivated a regional malaria elimination agenda. We aimed to use molecular genotyping to assess antimalarial drug resistance selection and spread in the Greater Mekong subregion.

Methods: In this observational study, we tested Plasmodium falciparum isolates from Myanmar, northeastern Thailand, southern Laos, and western Cambodia for PfKelch13 mutations and for Pfplasmepsin2 gene amplification (indicating piperaquine resistance). We collected blood spots from patients with microscopy or rapid test confirmed uncomplicated falciparum malaria. We used microsatellite genotyping to assess genetic relatedness.

Findings: As part of studies on the epidemiology of artemisinin-resistant malaria between Jan 1, 2008, and Dec 31, 2015, we collected 434 isolates. In 2014-15, a single long PfKelch13 C580Y haplotype (-50 to +31·5 kb) lineage, which emerged in western Cambodia in 2008, was detected in 65 of 88 isolates from northeastern Thailand, 86 of 111 isolates from southern Laos, and 14 of 14 isolates from western Cambodia, signifying a hard transnational selective sweep. Pfplasmepsin2 amplification occurred only within this lineage, and by 2015 these closely related parasites were found in ten of the 14 isolates from Cambodia and 15 of 15 isolates from northeastern Thailand. C580Y mutated parasites from Myanmar had a different genetic origin.

Interpretation: Our results suggest that the dominant artemisinin-resistant P falciparum C580Y lineage probably arose in western Cambodia and then spread to Thailand and Laos, outcompeting other parasites and acquiring piperaquine resistance. The emergence and spread of fit artemisinin-resistant P falciparum parasite lineages, which then acquire partner drug resistance across the Greater Mekong subregion, threatens regional malaria control and elimination goals. Elimination of falciparum malaria from this region should be accelerated while available antimalarial drugs still remain effective.

Funding: The Wellcome Trust and the Bill and Melinda Gates Foundation.

Citing Articles

Advancing artemisinin resistance monitoring using a high sensitivity ddPCR assay for Pfkelch13 mutation detection in Asia.

Srisutham S, Saejeng A, Khantikul N, Sugaram R, Sangsri R, Dondorp A Sci Rep. 2025; 15(1):4869.

PMID: 39929914 PMC: 11811204. DOI: 10.1038/s41598-025-86630-7.

Development and experimental validation of a machine learning model for the prediction of new antimalarials.

Kore M, Acharya D, Sharma L, Vembar S, Sundriyal S BMC Chem. 2025; 19(1):28.

PMID: 39885590 PMC: 11783816. DOI: 10.1186/s13065-025-01395-4.

Emergence and Rising Prevalence of Artemisinin Partial Resistance Marker Kelch13 P441L in a Low Malaria Transmission Setting in Southern Zambia.

Martin A, Sadler J, Simkin A, Musonda M, Katowa B, Matoba J medRxiv. 2025; .

PMID: 39802768 PMC: 11722444. DOI: 10.1101/2025.01.02.24319706.

Low prevalence of copy number variation in pfmdr1 and pfpm2 in Plasmodium falciparum isolates from southern Angola.

Duarte D, Manuel F, Dias A, Sacato E, Taleingue E, Daniel E Malar J. 2025; 24(1):5.

PMID: 39794826 PMC: 11720348. DOI: 10.1186/s12936-024-05240-2.

Anopheles mosquitoes in Mondulkiri forest, Cambodia: abundance, distribution, seasonal patterns and Plasmodium prevalence.

Boyer S, Doeurk B, Rakotonirina A, Chy S, Vong C, Piv E Malar J. 2025; 24(1):6.

PMID: 39794774 PMC: 11720960. DOI: 10.1186/s12936-024-05166-9.

References

Amaratunga C, Lim P, Suon S, Sreng S, Mao S, Sopha C . Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect Dis. 2016; 16(3):357-65. PMC: 4792715. DOI: 10.1016/S1473-3099(15)00487-9. View

Witkowski B, Duru V, Khim N, Ross L, Saintpierre B, Beghain J . A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study. Lancet Infect Dis. 2016; 17(2):174-183. PMC: 5266792. DOI: 10.1016/S1473-3099(16)30415-7. View

Imwong M, Nguyen T, Tripura R, Peto T, Lee S, Maung Lwin K . The epidemiology of subclinical malaria infections in South-East Asia: findings from cross-sectional surveys in Thailand-Myanmar border areas, Cambodia, and Vietnam. Malar J. 2015; 14:381. PMC: 4590703. DOI: 10.1186/s12936-015-0906-x. View

Leang R, Taylor W, Mey Bouth D, Song L, Tarning J, Char M . Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment. Antimicrob Agents Chemother. 2015; 59(8):4719-26. PMC: 4505193. DOI: 10.1128/AAC.00835-15. View

Phyo A, Ashley E, Anderson T, Bozdech Z, Carrara V, Sriprawat K . Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai-Myanmar Border (2003-2013): The Role of Parasite Genetic Factors. Clin Infect Dis. 2016; 63(6):784-791. PMC: 4996140. DOI: 10.1093/cid/ciw388. View

White N . Can new treatment developments combat resistance in malaria?. Expert Opin Pharmacother. 2016; 17(10):1303-7. DOI: 10.1080/14656566.2016.1187134. View

Nair S, Nash D, Sudimack D, Jaidee A, Barends M, Uhlemann A . Recurrent gene amplification and soft selective sweeps during evolution of multidrug resistance in malaria parasites. Mol Biol Evol. 2006; 24(2):562-73. DOI: 10.1093/molbev/msl185. View

Menard D, Khim N, Beghain J, Adegnika A, Shafiul-Alam M, Amodu O . A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms. N Engl J Med. 2016; 374(25):2453-64. PMC: 4955562. DOI: 10.1056/NEJMoa1513137. View

Spring M, Lin J, Manning J, Vanachayangkul P, Somethy S, Bun R . Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study. Lancet Infect Dis. 2015; 15(6):683-91. DOI: 10.1016/S1473-3099(15)70049-6. View

10.

Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T . Intercontinental spread of pyrimethamine-resistant malaria. Science. 2004; 305(5687):1124. DOI: 10.1126/science.1098876. View

11.

Takala-Harrison S, Jacob C, Arze C, Cummings M, Silva J, Dondorp A . Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. J Infect Dis. 2014; 211(5):670-9. PMC: 4334802. DOI: 10.1093/infdis/jiu491. View

12.

Miotto O, Amato R, Ashley E, MacInnis B, Almagro-Garcia J, Amaratunga C . Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat Genet. 2015; 47(3):226-34. PMC: 4545236. DOI: 10.1038/ng.3189. View

13.

Cheeseman I, Miller B, Nair S, Nkhoma S, Tan A, Tan J . A major genome region underlying artemisinin resistance in malaria. Science. 2012; 336(6077):79-82. PMC: 3355473. DOI: 10.1126/science.1215966. View

14.

Imwong M, Jindakhad T, Kunasol C, Sutawong K, Vejakama P, Dondorp A . An outbreak of artemisinin resistant falciparum malaria in Eastern Thailand. Sci Rep. 2015; 5:17412. PMC: 4663761. DOI: 10.1038/srep17412. View

15.

Tripura R, Peto T, Chalk J, Lee S, Sirithiranont P, Nguon C . Persistent Plasmodium falciparum and Plasmodium vivax infections in a western Cambodian population: implications for prevention, treatment and elimination strategies. Malar J. 2016; 15:181. PMC: 4806483. DOI: 10.1186/s12936-016-1224-7. View

16.

Amato R, Lim P, Miotto O, Amaratunga C, Dek D, Pearson R . Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study. Lancet Infect Dis. 2016; 17(2):164-173. PMC: 5564489. DOI: 10.1016/S1473-3099(16)30409-1. View

17.

Talundzic E, Okoth S, Congpuong K, Plucinski M, Morton L, Goldman I . Selection and spread of artemisinin-resistant alleles in Thailand prior to the global artemisinin resistance containment campaign. PLoS Pathog. 2015; 11(4):e1004789. PMC: 4383523. DOI: 10.1371/journal.ppat.1004789. View

18.

. Genomic epidemiology of artemisinin resistant malaria. Elife. 2016; 5. PMC: 4786412. DOI: 10.7554/eLife.08714. View

19.

Dondorp A, Nosten F, Yi P, Das D, Phyo A, Tarning J . Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009; 361(5):455-67. PMC: 3495232. DOI: 10.1056/NEJMoa0808859. View

20.

Duru V, Khim N, Leang R, Kim S, Domergue A, Kloeung N . Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations. BMC Med. 2015; 13:305. PMC: 4688949. DOI: 10.1186/s12916-015-0539-5. View